Phreesia Operating Margin 2019-2025 | PHR
Current and historical operating margin for Phreesia (PHR) over the last 10 years. The current operating profit margin for Phreesia as of April 30, 2025 is -9.83%.
| Phreesia Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-04-30 | $0.44B | $-0.04B | -9.66% |
| 2025-01-31 | $0.42B | $-0.06B | -13.81% |
| 2024-10-31 | $0.41B | $-0.08B | -19.75% |
| 2024-07-31 | $0.39B | $-0.10B | -25.13% |
| 2024-04-30 | $0.37B | $-0.12B | -31.55% |
| 2024-01-31 | $0.36B | $-0.14B | -38.38% |
| 2023-10-31 | $0.34B | $-0.15B | -43.36% |
| 2023-07-31 | $0.32B | $-0.16B | -48.44% |
| 2023-04-30 | $0.30B | $-0.16B | -54.30% |
| 2023-01-31 | $0.28B | $-0.18B | -62.99% |
| 2022-10-31 | $0.26B | $-0.18B | -70.23% |
| 2022-07-31 | $0.25B | $-0.18B | -73.47% |
| 2022-04-30 | $0.23B | $-0.16B | -69.30% |
| 2022-01-31 | $0.21B | $-0.12B | -55.40% |
| 2021-10-31 | $0.20B | $-0.08B | -40.10% |
| 2021-07-31 | $0.18B | $-0.05B | -27.37% |
| 2021-04-30 | $0.16B | $-0.03B | -19.02% |
| 2021-01-31 | $0.15B | $-0.03B | -16.89% |
| 2020-10-31 | $0.14B | $-0.02B | -15.83% |
| 2020-07-31 | $0.13B | $-0.02B | -13.43% |
| 2020-04-30 | $0.13B | $-0.02B | -12.31% |
| 2020-01-31 | $0.13B | $-0.02B | -12.00% |
| 2019-07-31 | $0.08B | $-0.01B | -13.10% |
| 2019-04-30 | $0.08B | $-0.01B | -10.26% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.609B | $0.420B |
| Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.159B | 58.73 |
| Doximity (DOCS) | United States | $11.724B | 54.28 |
| Hims & Hers Health (HIMS) | United States | $11.606B | 120.58 |
| Tempus AI (TEM) | United States | $10.382B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.374B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.760B | 58.76 |
| Hinge Health (HNGE) | United States | $3.663B | 0.00 |
| Privia Health (PRVA) | United States | $2.509B | 171.50 |
| Enovis (ENOV) | United States | $1.745B | 9.73 |
| Schrodinger (SDGR) | United States | $1.559B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.537B | 0.00 |
| 10x Genomics (TXG) | United States | $1.523B | 0.00 |
| Azenta (AZTA) | United States | $1.469B | 68.25 |
| Evolent Health (EVH) | United States | $1.343B | 114.40 |
| Omnicell (OMCL) | United States | $1.301B | 22.96 |
| Claritev (CTEV) | United States | $0.725B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.549B | 0.00 |
| Veradigm (MDRX) | United States | $0.499B | 0.00 |
| Standard BioTools (LAB) | United States | $0.471B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.443B | 0.00 |
| Talkspace (TALK) | United States | $0.416B | 124.25 |
| TruBridge (TBRG) | United States | $0.326B | 722.33 |
| Outset Medical (OM) | United States | $0.321B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.271B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.264B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.241B | 0.00 |
| CapsoVision (CV) | United States | $0.221B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.188B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| American Well (AMWL) | United States | $0.129B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.121B | 0.00 |
| Pulmonx (LUNG) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.104B | 0.00 |
| CareCloud (CCLD) | United States | $0.102B | 3.87 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.088B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.047B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |